BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 23148932)

  • 1. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis.
    Chou HH; Kuo CJ; Hsu JT; Chen TH; Lin CJ; Tseng JH; Yeh TS; Hwang TL; Jan YY
    Am J Surg; 2013 Jun; 205(6):623-30. PubMed ID: 23036602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.
    Park JM; Kim SW; Nam KW; Cho YK; Lee IS; Choi MG; Chung IS; Song KY; Park CH; Jung CK
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1132-5. PubMed ID: 19369881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
    Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
    Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study.
    Marrelli D; Roviello F; de Manzoni G; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Folli S; Cordiano C; Pinto E;
    World J Surg; 2002 Sep; 26(9):1160-5. PubMed ID: 12209247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma.
    Hsu JT; Lin CJ; Sung CM; Yeh HC; Chen TH; Chen TC; Chiang KC; Yeh TS; Hwang TL; Jan YY
    Eur J Surg Oncol; 2013 Nov; 39(11):1287-93. PubMed ID: 23973513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
    Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
    Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
    Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategy for patients with pN0 gastric carcinoma.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
    Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
    Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.